Lynne Murray
6Patents
1h-index
10Co-inventors
44Inventor score
Filing activity: Oct 26, 2007 → Oct 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9233140B2 | Treatment methods for hypersensitive disorders | Human Necessities | 2 | Active |
| US10829549B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US9944697B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10702583B2 | Treatment methods for autoimmune disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US7754207B2 | Methods of treating pulmonary fibrosis | Human Necessities | 0 | Active |
| US11414484B2 | Anti-CCL17 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.